{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:36:08Z","timestamp":1789558568843,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1023\/b:caco.0000024245.24880.8a","type":"journal-article","created":{"date-parts":[[2004,4,17]],"date-time":"2004-04-17T01:11:30Z","timestamp":1082164290000},"page":"255-265","source":"Crossref","is-referenced-by-count":182,"title":["Plasma 1,25-Dihydroxy- and 25-Hydroxyvitamin D and Subsequent Risk of Prostate Cancer"],"prefix":"10.1007","volume":"15","author":[{"given":"Elizabeth A.","family":"Platz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Leitzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce W.","family":"Hollis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter C.","family":"Willett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Giovannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"5267656_CR1","first-page":"1307","volume":"10","author":"GG Schwartz","year":"1990","unstructured":"Schwartz GG, Hulka BS (1990) Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res\n10: 1307\u20131311.","journal-title":"Anticancer Res"},{"key":"5267656_CR2","first-page":"467","volume":"2","author":"EH Corder","year":"1993","unstructured":"Corder EH, Guess HA, Hulka BS, et al. (1993) Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev\n2: 467\u2013472.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5267656_CR3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00051795","volume":"6","author":"MM Braun","year":"1995","unstructured":"Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW (1995) Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control\n6: 235\u2013239.","journal-title":"Cancer Causes Control"},{"key":"5267656_CR4","first-page":"121","volume":"5","author":"PH Gann","year":"1996","unstructured":"Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ (1996) Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev\n5: 121\u2013126.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5267656_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1023\/A:1008875819232","volume":"9","author":"AM Nomura","year":"1998","unstructured":"Nomura AM, Stemmermann GN, Lee J, et al. (1998) Serum vitamin D metabolite levels and the subsequent development of prostate cancer. Cancer Causes Control\n9: 425\u2013432.","journal-title":"Cancer Causes Control"},{"key":"5267656_CR6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1008923802001","volume":"11","author":"MH Ahonen","year":"2000","unstructured":"Ahonen MH, Tenkanen LT, Hakama M, Tuohimaa P (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control\n11: 847\u2013852.","journal-title":"Cancer Causes Control"},{"key":"5267656_CR7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/clinchem\/39.3.529","volume":"39","author":"BW Hollis","year":"1993","unstructured":"Hollis BW, Kamerud JQ, Salvaag SR, Lorenz JD, Napoli JL (1993) Determination of vitamin D status by radioimmunoassay with an 125I-labelled tracer. Clin Chem\n39: 529\u2013533.","journal-title":"Clin Chem"},{"key":"5267656_CR8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1152\/physrev.1980.60.2.551","volume":"60","author":"DR Fraser","year":"1980","unstructured":"Fraser DR (1980) Regulation of the metabolism of vitamin D. Physiol Rev\n60: 551\u2013613.","journal-title":"Physiol Rev"},{"key":"5267656_CR9","first-page":"471a","volume":"149","author":"RR Bahnson","year":"1993","unstructured":"Bahnson RR, Oeler T, Trump D, Smith D, Schwartz GG (1993) Inhibition of human prostatic carcinoma cell lines by 1,25 dihydroxyvitamin D3 and vitamin D analogs. J Urol\n149: 471a.","journal-title":"J Urol"},{"key":"5267656_CR10","first-page":"805","volume":"54","author":"DM Peehl","year":"1994","unstructured":"Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D (1994) Antiproliferative effects of 1,25-dihydroxyvita-min D3 on primary cultures of human prostatic cells. Cancer Res\n54: 805\u2013810.","journal-title":"Cancer Res"},{"key":"5267656_CR11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/pros.2990260203","volume":"26","author":"RH Drivdahl","year":"1995","unstructured":"Drivdahl RH, Loop SM, Andress DL, Ostenson RC (1995) IGF-binding proteins in human prostate tumor cells: expression and regulation by 1,25-dihydroxyvitamin D3. Prostate\n26: 72\u201379.","journal-title":"Prostate"},{"key":"5267656_CR12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1097-0045(199603)28:3<182::AID-PROS5>3.0.CO;2-H","volume":"28","author":"M Esquenet","year":"1996","unstructured":"Esquenet M, Swinnen JV, Heyns W, Verhoeven G (1996) Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1a,25-dihydroxycholecalciferol, all-transretinoic acid, 9-cis retinoic acid, and phenylacetate. Prostate\n28: 182\u2013194.","journal-title":"Prostate"},{"key":"5267656_CR13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/bbrc.1996.0859","volume":"223","author":"T-C Hsieh","year":"1996","unstructured":"Hsieh T-C, Ng C-Y, Mallouh C, Tazaki H, Wu JM (1996) Regulation of growth, PSA\/PAP and androgen receptor expression by 1a,25-dihydroxyvitamin D3 in the androgen-dependent LNCaP cells. Biochem Biophys Res Comm\n223: 141\u2013146.","journal-title":"Biochem Biophys Res Comm"},{"key":"5267656_CR14","first-page":"442","volume":"58","author":"E Giovannucci","year":"1958","unstructured":"Giovannucci E, Rimm EB, Wolk A, et al. (1958) Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res\n58: 442\u2013447.","journal-title":"Cancer Res"},{"key":"5267656_CR15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/oxfordjournals.aje.a113804","volume":"119","author":"MJ Stampfer","year":"1984","unstructured":"Stampfer MJ, Willett WC, Speizer FE, et al. (1984) Test of the National Death Index. Am J Epidemiol\n119: 837\u2013839.","journal-title":"Am J Epidemiol"},{"key":"5267656_CR16","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/clinchem\/42.4.586","volume":"42","author":"BW Hollis","year":"1996","unstructured":"Hollis BW, Kamerud JQ, Kurkowski A, Beaulieu J, Napoli JL (1996) Quanti.cation of circulating 1,25-dihydroxyvitamin D by radioimmunoassay with 125I-labeled tracer. Clin Chem\n42: 586\u2013592.","journal-title":"Clin Chem"},{"key":"5267656_CR17","volume-title":"Taber's Cyclopedic Medical Dictionary","year":"1989","unstructured":"Thomas CL, ed. (1989) Taber's Cyclopedic Medical Dictionary. 16th edn. Philadelphia: F.A. Davis Company.","edition":"16th edn."},{"key":"5267656_CR18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1532-5415.1991.tb01615.x","volume":"39","author":"FM Gloth","year":"1991","unstructured":"Gloth FM, Tobin JD, Sherman SS, Hollis BW (1991) Is the recommended daily allowance for vitamin D too low for the homebound elderly. J Am Geriatr Soc\n39: 137\u2013141.","journal-title":"J Am Geriatr Soc"},{"key":"5267656_CR19","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJM198904133201506","volume":"320","author":"H Reichel","year":"1989","unstructured":"Reichel H, Koeffler HP, Norman AW (1989) The role of the vitamin D endocrine system in health and disease. N Engl J Med\n320: 980\u2013991.","journal-title":"N Engl J Med"},{"key":"5267656_CR20","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/endo.132.5.7682937","volume":"132","author":"RJ Skowronski","year":"1993","unstructured":"Skowronski RJ, Peehl DM, Feldman D (1993) Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology\n132: 1952\u20131960.","journal-title":"Endocrinology"},{"key":"5267656_CR21","first-page":"997","volume":"1","author":"GJ Miller","year":"1995","unstructured":"Miller GJ, Stapleton GE, Hedlund TE, Moffatt KA (1995) Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1a,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Clin Cancer Res\n1: 997\u20131003.","journal-title":"Clin Cancer Res"},{"key":"5267656_CR22","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/endo.137.5.8612485","volume":"137","author":"TE Hedlund","year":"1996","unstructured":"Hedlund TE, Moffatt KA, Miller GJ (1996) Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1a,25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. Endocrinology\n137: 1554\u20131561.","journal-title":"Endocrinology"},{"key":"5267656_CR23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0090-4295(99)80221-0","volume":"46","author":"GG Schwartz","year":"1995","unstructured":"Schwartz GG, Hill CC, Oeler TA, Becich MJ, Bahnson RR (1995) 1,25-dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo. Urology\n46: 365\u2013369.","journal-title":"Urology"},{"key":"5267656_CR24","first-page":"5621","volume":"55","author":"MS Lucia","year":"1995","unstructured":"Lucia MS, Anzano MA, Slayter MV, et al. (1995) Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate. Cancer Res\n55: 5621\u20135627.","journal-title":"Cancer Res"},{"key":"5267656_CR25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1023\/A:1008823601897","volume":"9","author":"JM Chan","year":"1998","unstructured":"Chan JM, Giovannucci E, Andersson SO, Yuen J, Adami H-O, Wolk A (1998) Dairy products, calcium, phosphorus, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes Control\n9: 559\u2013566.","journal-title":"Cancer Causes Control"},{"key":"5267656_CR26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1023\/A:1008947201132","volume":"11","author":"JM Chan","year":"2000","unstructured":"Chan JM, Pietinen P, Virtanen M, Malila N, Tangrea J (2000) Diet and prostate cancer risk in a cohort of smokers, with a specificfocus on calcium and phosphorus (Finland). Cancer Causes Control\n11: 859\u2013867.","journal-title":"Cancer Causes Control"},{"key":"5267656_CR27","first-page":"391","volume":"7","author":"GG Schwartz","year":"1998","unstructured":"Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF (1998) Human prostate cells synthesize 1,25-dihydroxyvitamin D3 form 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev\n7: 391\u2013395.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5267656_CR28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0303-7207(00)00226-4","volume":"164","author":"V Sung","year":"2000","unstructured":"Sung V, Feldman D (2000) 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration. Mol Cell Endocrinol\n164: 133\u2013143.","journal-title":"Mol Cell Endocrinol"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:CACO.0000024245.24880.8a.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:CACO.0000024245.24880.8a\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:CACO.0000024245.24880.8a.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T18:37:13Z","timestamp":1750963033000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:CACO.0000024245.24880.8a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["5267656"],"URL":"https:\/\/doi.org\/10.1023\/b:caco.0000024245.24880.8a","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}